Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
The primary objective for this study is to establish the superiority of GSK1120212 over chemotherapy with respect to progression-free survival for subjects with advanced/metastatic BRAF V600E mutation-positive melanoma without a history of prior brain metastases.
Inclusion criteria
- Advanced or metastatic BRAF V600E/K mutation-positive melanoma